A phase 1/2 study that combines stereotactic ablative radiation to prostate cancer metastases, followed by treatment with ADXS-PSA
Phase of Trial: Phase I/II
Latest Information Update: 01 Dec 2015
At a glance
- Drugs ADXS 31142 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Dec 2015 According to the Advaxis Inc. media release, FDA has placed ADXS- PSA trials on clinical hold.
- 01 Dec 2015 Status changed from planning to suspended, according to the Advaxis Inc. media release.
- 07 Aug 2015 New trial record